当前位置: X-MOL首页 › SCI期刊查询及投稿分析系统 › Cellular & Molecular Immunology杂志
Cellular & Molecular Immunology
基本信息
期刊名称 | Cellular & Molecular Immunology CELL MOL IMMUNOL |
---|---|
期刊ISSN | 1672-7681 |
期刊官方网站 | https://www.nature.com/cmi |
是否OA | No |
出版商 | Springer Nature |
出版周期 | Bimonthly |
文章处理费 | 登录后查看 |
始发年份 | 2008 |
年文章数 | 100 |
影响因子 | 21.8(2023) scijournal影响因子 greensci影响因子 |
中科院SCI期刊分区
大类学科 | 小类学科 | Top | 综述 |
---|---|---|---|
医学1区 | IMMUNOLOGY 免疫学1区 | 是 | 否 |
CiteScore
CiteScore排名 | CiteScore | SJR | SNIP | ||
---|---|---|---|---|---|
学科 | 排名 | 百分位 | 5.23 | 2.728 | 1.657 |
Medicine Infectious Diseases |
14 / 272 | 95% |
|||
Medicine Immunology and Allergy |
25 / 188 | 86% |
|||
Immunology and Microbiology Immunology |
32 / 198 | 84% |
补充信息
自引率 | 1.4% |
---|---|
H-index | 64 |
SCI收录状况 | Science Citation Index Expanded |
官方审稿时间 | 登录后查看 |
网友分享审稿时间 | 数据统计中,敬请期待。 |
接受率 | 登录后查看 |
PubMed Central (PMC) | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1672-7681%5BISSN%5D |
投稿指南
期刊投稿网址 | https://mts-cmi.nature.com/ |
---|---|
收稿范围 | Cellular & Molecular Immunology is a monthly journal from the Chinese Society of Immunology and the University of Science and Technology of China. Covering both basic immunology research and clinical applications, Cellular & Molecular Immunology provides the latest information and advancements in our understanding of the immunological response of the host, both in vitro and in vivo. The journal publishes Articles, Review Articles, Mini Reviews and Short Communications and Correspondences in all areas of cellular and molecular immunology, including but not limited to: clinical immunology comparative immunology immunobiology immunogenetics immunological techniques immunopathology immunopharmacology infection immunology neuroimmunology transplantation immunology tumor immunology veterinary immunology As China's first English-language immunology journal, Cellular & Molecular Immunology is designed to serve both the Chinese and international communities as a vehicle to rapidly disseminate the latest studies in this field. The journal welcomes submissions that explore novel ideas or un- or contra-orthodox approaches, as long as they are underpinned by conventional scientific practice and present falsifiable hypotheses that are tested with empirical methods and evidence. Manuscripts must provide evidence that can be critically evaluated, and where applicable: define disorders and clinical symptoms by standard clinical terms (e.g. allergy, asthma, lupus, etc.) deem results 'significant' only using standard statistical methods in biological effects/outcomes studies use consistent and defined amounts and mixtures of herbal formulas, or use purified monomer extracts. Terms that may be ambiguous to the broad audience of the journal should be clearly defined within the manuscript. |
收录体裁 | Articles Reviews Articles Research Highlights Editorials Correspondence News and Views |
投稿指南 | https://www.nature.com/cmi/authors-and-referees |
投稿模板 | |
参考文献格式 | https://endnote.com/downloads/styles/ |
编辑信息 |
Editor-in-Chief Xuetao Cao, Beijing Zhigang Tian, Hefei Associate Editors M. Eric Gershwin, Davis Bin Gao, Bethesda Liwei Lu, Hongkong Antonio Bertoletti, Singapore Stipan Jonjic, Rijeka Weiping Zou, Michigan |
我要分享 (欢迎您来完善期刊的资料,分享您的实际投稿经验)